---
document_datetime: 2023-09-21 19:21:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/capecitabine-teva-epar-all-authorised-presentations_en.pdf
document_name: capecitabine-teva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0803255
conversion_datetime: 2025-12-14 15:59:31.564408
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Name              | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging                  | Package size   |
|-----------------|-------------------|------------|-----------------------|---------------------------|----------------------------|----------------|
| EU/1/12/761/001 | Capecitabine Teva | 150 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC/ alu) | 60 tablets     |
| EU/1/12/761/002 | Capecitabine Teva | 500 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC/ alu) | 120 tablets    |